Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | %Female (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124 | Farmaceutico Hospitales | journal | 0.100 Q4 | 3 | 14 | 80 | 181 | 0 | 63 | 0.00 | 12.93 | 69.23 | |
123 | Giornale di Neuropsicofarmacologia | journal | 0.100 Q4 | 1 | 0 | 45 | 0 | 0 | 38 | 0.00 | 0.00 | 0.00 | |
122 | Pharmacy News | journal | 0.100 Q4 | 1 | 98 | 723 | 2 | 0 | 248 | 0.00 | 0.02 | 52.63 | |
121 | Drug Topics | journal | 0.101 Q4 | 8 | 133 | 1116 | 28 | 8 | 867 | 0.01 | 0.21 | 35.71 | |
120 | Journal of Pharmacy of Istanbul University | journal | 0.101 Q4 | 11 | 0 | 26 | 0 | 0 | 26 | 0.00 | 0.00 | 0.00 | |
119 | PZ Prisma | journal | 0.101 Q4 | 5 | 32 | 99 | 624 | 6 | 87 | 0.06 | 19.50 | 38.24 | |
118 | Perspectives in Medicinal Chemistry | journal | 0.103 Q4 | 17 | 3 | 7 | 212 | 0 | 7 | 0.00 | 70.67 | 25.00 | |
117 | Anales de la Real Academia Nacional de Medicina | journal | 0.104 Q4 | 7 | 29 | 128 | 0 | 7 | 128 | 0.03 | 0.00 | 3.33 | |
116 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.104 Q4 | 29 | 5 | 9 | 374 | 1 | 3 | 0.11 | 74.80 | 0.00 | |
115 | Pharmakeftiki | journal | 0.108 Q4 | 6 | 13 | 16 | 751 | 1 | 15 | 0.06 | 57.77 | 47.06 | |
114 | Actualites Pharmaceutiques Hospitalieres | journal | 0.110 Q4 | 3 | 30 | 123 | 426 | 3 | 102 | 0.03 | 14.20 | 48.28 | |
113 | Fabad Journal of Pharmaceutical Sciences | journal | 0.111 Q4 | 19 | 24 | 73 | 1031 | 5 | 72 | 0.04 | 42.96 | 47.22 | |
112 | Acta Pharmaceutica Hungarica (discontinued) | journal | 0.112 Q4 | 14 | 20 | 73 | 687 | 13 | 73 | 0.14 | 34.35 | 48.08 | |
111 | EPC - European Pharmaceutical Contractor | journal | 0.112 Q4 | 3 | 75 | 285 | 368 | 3 | 275 | 0.01 | 4.91 | 28.71 | |
110 | Revista Mexicana de Ciencias Farmaceuticas | journal | 0.125 Q4 | 11 | 27 | 98 | 612 | 6 | 78 | 0.06 | 22.67 | 64.37 | |
109 | Acta Pharmaceutica Sciencia | journal | 0.129 Q4 | 23 | 36 | 55 | 696 | 5 | 55 | 0.11 | 19.33 | 35.56 | |
108 | Ankara Universitesi Eczacilik Fakultesi Dergisi | journal | 0.129 Q4 | 13 | 22 | 61 | 874 | 6 | 61 | 0.05 | 39.73 | 68.33 | |
107 | Anales de la Real Academia Nacional de Farmacia (discontinued) | journal | 0.130 Q4 | 10 | 29 | 104 | 1093 | 15 | 101 | 0.15 | 37.69 | 43.86 | |
106 | Drug Delivery System | journal | 0.130 Q4 | 9 | 29 | 88 | 706 | 11 | 88 | 0.12 | 24.34 | 12.00 | |
105 | International Journal of Essential Oil Therapeutics | journal | 0.130 Q4 | 15 | 31 | 59 | 963 | 19 | 58 | 0.32 | 31.06 | 38.46 | |
104 | Journal of Pharmacy Technology | journal | 0.130 Q4 | 16 | 31 | 93 | 796 | 11 | 90 | 0.14 | 25.68 | 50.59 | |
103 | EBR - European Biopharmaceutical Review | journal | 0.131 Q4 | 6 | 64 | 246 | 456 | 5 | 242 | 0.02 | 7.13 | 26.09 | |
102 | Pharmazie in Unserer Zeit | journal | 0.131 Q4 | 13 | 89 | 243 | 1085 | 36 | 191 | 0.16 | 12.19 | 41.41 | |
101 | Farmacevtski Vestnik (discontinued) | journal | 0.132 Q4 | 5 | 57 | 109 | 1275 | 8 | 106 | 0.09 | 22.37 | 57.53 | |
100 | Journal de Pharmacie de Belgique | journal | 0.135 Q3 | 13 | 33 | 74 | 509 | 12 | 70 | 0.13 | 15.42 | 42.22 | |
99 | Pharmaceutical Engineering | journal | 0.135 Q3 | 18 | 50 | 164 | 352 | 12 | 146 | 0.07 | 7.04 | 25.76 | |
98 | Pharmaceutical Outsourcing | journal | 0.135 Q3 | 7 | 46 | 118 | 182 | 7 | 118 | 0.07 | 3.96 | 28.57 | |
97 | Scientia Pharmaceutica | journal | 0.138 Q3 | 54 | 54 | 76 | 1462 | 28 | 75 | 0.39 | 27.07 | 34.36 | |
96 | Canadian Pharmacists Journal | journal | 0.143 Q3 | 30 | 84 | 372 | 836 | 32 | 210 | 0.08 | 9.95 | 59.55 | |
95 | Saudi Pharmaceutical Journal | journal | 0.143 Q3 | 76 | 40 | 86 | 1135 | 30 | 86 | 0.31 | 28.38 | 31.78 | |
94 | Ars Pharmaceutica (discontinued) | journal | 0.145 Q3 | 21 | 21 | 87 | 517 | 25 | 87 | 0.27 | 24.62 | 58.14 | |
93 | Clinical Research and Regulatory Affairs | journal | 0.147 Q3 | 18 | 12 | 37 | 303 | 11 | 37 | 0.25 | 25.25 | 21.62 | |
92 | Journal of Pharmaceutical Finance, Economics and Policy | journal | 0.152 Q3 | 8 | 0 | 52 | 0 | 11 | 40 | 0.13 | 0.00 | 0.00 | |
91 | Farmaceuticky Obzor (discontinued) | journal | 0.156 Q3 | 7 | 31 | 102 | 616 | 8 | 99 | 0.04 | 19.87 | 48.00 | |
90 | Pharmaceutical Technology Europe | journal | 0.156 Q3 | 19 | 110 | 325 | 528 | 30 | 252 | 0.09 | 4.80 | 25.55 | |
89 | Drug Design, Development and Therapy | journal | 0.157 Q3 | 94 | 22 | 30 | 1112 | 11 | 27 | 0.37 | 50.55 | 32.50 | |
88 | Annales Pharmaceutiques Francaises | journal | 0.167 Q3 | 31 | 57 | 149 | 1570 | 64 | 141 | 0.41 | 27.54 | 30.69 | |
87 | Korean Journal of Pharmacognosy | journal | 0.175 Q3 | 18 | 64 | 189 | 1476 | 50 | 189 | 0.26 | 23.06 | 42.11 | |
86 | American Pharmaceutical Review | journal | 0.181 Q3 | 26 | 88 | 314 | 1412 | 97 | 313 | 0.27 | 16.05 | 26.00 | |
85 | International Journal of Pharmaceutical Compounding | journal | 0.190 Q3 | 13 | 155 | 352 | 1166 | 30 | 328 | 0.08 | 7.52 | 40.16 | |
84 | Pharmazeutische Industrie | journal | 0.195 Q3 | 19 | 188 | 690 | 965 | 47 | 662 | 0.08 | 5.13 | 26.44 | |
83 | Pharmaceutical Care Espana (discontinued) | journal | 0.204 Q3 | 11 | 26 | 84 | 430 | 10 | 68 | 0.09 | 16.54 | 60.00 | |
82 | Journal of Generic Medicines (discontinued) | journal | 0.205 Q3 | 16 | 35 | 128 | 470 | 29 | 119 | 0.13 | 13.43 | 30.95 | |
81 | Acta Poloniae Pharmaceutica | journal | 0.206 Q3 | 52 | 95 | 306 | 2209 | 168 | 306 | 0.50 | 23.25 | 48.25 | |
80 | Turkish Journal of Pharmaceutical Sciences | journal | 0.209 Q3 | 22 | 22 | 49 | 522 | 12 | 49 | 0.12 | 23.73 | 45.83 | |
79 | Pharmaceutical Journal | journal | 0.239 Q3 | 28 | 1044 | 3204 | 972 | 146 | 763 | 0.03 | 0.93 | 44.64 | |
78 | Pharmacy Practice | journal | 0.241 Q3 | 35 | 35 | 97 | 908 | 62 | 97 | 0.53 | 25.94 | 62.07 | |
77 | S.T.P. Pharma Pratiques | journal | 0.241 Q3 | 10 | 27 | 100 | 321 | 14 | 99 | 0.15 | 11.89 | 41.54 | |
76 | Yakugaku Zasshi | journal | 0.247 Q2 | 47 | 189 | 612 | 4511 | 438 | 591 | 0.64 | 23.87 | 24.79 | |
75 | Journal of Cardiovascular Translational Research | journal | 0.251 Q2 | 60 | 68 | 62 | 2852 | 18 | 55 | 0.29 | 41.94 | 35.47 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®